Projects per year
Personal profile
Biography
Shalini is a clinical addiction psychiatrist and has extensive experience working across alcohol and other drug (AOD) and mental health services. She is an Associate Professor (Research) and NHMRC Emerging Leader at Monash University, with research interests focusing on methamphetamine use, and management of co-occurring mental health substance use disorders, including PTSD and addiction.
Shalini is the inaugural clinical director of the Hamilton Centre, Victoria's statewide service for treatment, research and training in integrated care for mental health and addiction. Shalini is immediate past-chair of the binational Faculty of Addiction Psychiatry at the RANZCP (2017-2024), and served on the Board of Directors for the International Society of Addiction Medicine (2019-2024). Shalini is an executive committee member of the World Association of Dual Disorders (WADD), and is a Board Director for the Foundation for Alcohol Research and Education (FARE).
Research Interests
- methamphetamine use
- co-occurring mental health and substance use disorders (dual diagnosis) and integrated care
- management of co-occurring PTSD/trauma and addiction
- psychedelic assisted therapy for addiction and co-occurring mental health disorders
- women's health and addiction
- clinical trials and interventions for addiction
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Methamphetamine
- Psychosis
- Addiction
- Comorbidity
Collaborations and top research areas from the last five years
-
OLAM: Randomised double blind placebo controlled trial of oral lisdexamfetamine for methamphetamine withdrawal
Ezard, N. (Primary Chief Investigator (PCI)), Siefried, K. J. (Chief Investigator (CI)), Dunlop, A. (Chief Investigator (CI)), Lintzeris, N. (Chief Investigator (CI)), Shoptaw, S. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Carr, A. D. (Chief Investigator (CI)), Doyle, M. F. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Clifford, M. (Chief Investigator (CI)), Levin, F. (Associate Investigator (AI)), Bonomo, Y. (Associate Investigator (AI)), Lubman, D. (Associate Investigator (AI)), Nagle, J. (Associate Investigator (AI)), Cox, D. (Associate Investigator (AI)), Moller, C. (Associate Investigator (AI)), Christmass, M. (Associate Investigator (AI)), Acheson, L. (Associate Investigator (AI)), Mcketin, R. (Associate Investigator (AI)), Donoghoe, M. W. (Associate Investigator (AI)), Kuner, I. (Project Manager) & Logan, I. (Project Manager)
1/09/24 → 30/06/27
Project: Research
-
Scalable approaches to reducing alcohol and other drug use among traumatised young people: A RCT examining the safety, effectiveness, and cost-effectiveness of an integrated cognitivebehavioural therapy delivered via telehealth
Mills, K. L. (Primary Chief Investigator (PCI)), Cobham, V. E. (Chief Investigator (CI)), Peach, N. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Kay-Lambkin, F. (Chief Investigator (CI)), Chatterton, M. L. (Chief Investigator (CI)), Bendall, S. (Chief Investigator (CI)), Back, S. (Chief Investigator (CI)), Perrin , S. (Chief Investigator (CI)), Brady, K. T. (Chief Investigator (CI)), Kuner, I. (Project Manager) & Logan, I. (Project Manager)
1/01/23 → 31/12/26
Project: Research
-
Supporting vulnerable populations to maintain healthy ageing: Development of an enriched cohort study
Nielsen, S. (Primary Chief Investigator (PCI)), Lam, T. (Chief Investigator (CI)), Lalor, A. (Chief Investigator (CI)), Andrew, N. (Chief Investigator (CI)), Dietze, P. (Chief Investigator (CI)), Coulson, B. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Bright, S. J. (Chief Investigator (CI)), Hill, K. (Chief Investigator (CI)), Morgan, K. (Chief Investigator (CI)), Alfrey, L. (Chief Investigator (CI)) & Francia, L. (Chief Investigator (CI))
1/10/22 → 30/09/25
Project: Research
-
Transforming outcomes by investigating integrated treatment for methamphetamine use and trauma
Arunogiri, S. (Primary Chief Investigator (PCI))
1/07/22 → 30/06/28
Project: Research
-
A randomised controlled trial of cannabidiol (CBD) in the treatment of cannabis dependence
Lintzeris, N. (Primary Chief Investigator (PCI)), Lubman, D. (Chief Investigator (CI)), Doyle, M. F. (Chief Investigator (CI)), Dunlop, A. (Chief Investigator (CI)), Mills, L. (Chief Investigator (CI)), Harrod, M. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Malouf, P. (Chief Investigator (CI)), Haber, P. S. (Chief Investigator (CI)), Freeman, T. (Chief Investigator (CI)), Solowij, N. (Associate Investigator (AI)), Graham, R. (Associate Investigator (AI)), Childs, S. (Associate Investigator (AI)), Ella, S. (Associate Investigator (AI)), Montebello, M. (Associate Investigator (AI)), Nean, M. (Associate Investigator (AI)), Galettis, P. (Associate Investigator (AI)), Reeves, P. (Associate Investigator (AI)), Monds, L. A. (Associate Investigator (AI)) & Jefferies, M. (Associate Investigator (AI))
National Health and Medical Research Council (NHMRC) (Australia)
1/07/22 → 30/06/25
Project: Research
-
Peer navigation: a pilot study to improve recovery capital for alcohol and other drug telephone helpline callers
Peart, A., Horn, F., Rowland, B., Arunogiri, S., Jones, D., Manning, V. & Lubman, D. I., 2025, In: Drugs: Education, Prevention and Policy. 32, 2, p. 164-174 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Addiction Medicine and Psychiatry Workforce Training and Planning across Australia and New Zealand: Commentary on “Education and Training in Addiction Medicine and Psychology across Europe: a EUFAS Survey”
Arunogiri, S., Lubman, D. & Foulds, J., Jul 2024, In: European Addiction Research. 30, 3, p. 159–162 4 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access2 Citations (Scopus) -
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial
McKetin, R., Degan, T. J., Saunders, L., Nguyen, L., Dore, G., Shoptaw, S., Farrell, M., Degenhardt, L., Kelly, P. J., Turner, A., Clare, P. J., Dean, O. M., Arunogiri, S., Colledge-Frisby, S., Koeijers, J., Goodman-Meza, D., Sinclair, B., Reid, D., Hill, H. & Hayllar, J. & 17 others, , 22 Jun 2024, In: Trials. 25, 1, 12 p., 408.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
Bhardwaj, A. K., Mills, L., Doyle, M., Sahid, A., Montebello, M., Monds, L., Arunogiri, S., Haber, P., Lorenzetti, V., Lubman, D. I., Malouf, P., Harrod, M. E., Dunlop, A., Freeman, T. & Lintzeris, N., 4 Mar 2024, In: BMC Psychiatry. 24, 1, 16 p., 175.Research output: Contribution to journal › Article › Other › peer-review
Open Access5 Citations (Scopus) -
Cognitive Training During Midlife: A Systematic Review and Meta-Analysis
Zhu, C., Arunogiri, S., Li, Q., Thomas, E. H. X. & Gurvich, C., 2024, (Accepted/In press) In: Neuropsychology Review. 22 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access
Prizes
-
CPDD NIDA Women & Sex/Gender Junior Investigator Travel Award
Arunogiri, S. (Recipient), 13 May 2020
Prize: Prize (including medals and awards)
File
Activities
- 1 Contribution to conference
-
Australasian Professional Society on Alcohol and Other Drugs Conference 2024
Oliver, K. (Speaker), Arunogiri, S. (Organiser), Lubman, D. (Organiser), Cheetham, A. (Organiser), Heiss, L. (Organiser), Mcgee, T. (Organiser) & Killen, A. (Organiser)
30 Oct 2024Activity: Participating in or organising an event types › Contribution to conference
Press/Media
-
The Conversation: Women are drinking more during the pandemic, and it’s probably got a lot to do with their mental health
Arunogiri, S., Gurvich, C. & Kulkarni, J.
2/06/20
1 Media contribution
Press/Media: Expert Comment
-
The Conversation: Ambulance call-outs for pregabalin have spiked – here’s why
Arunogiri, S. & Crossin, R.
26/11/19
1 Media contribution
Press/Media: Expert Comment